Statistics for Fulgent Genetics (id:6486 FLGT)
Valuation metrics
Market cap
560.96M
Enterprise value
354.29M
Trailing P/E (ttm)
-3.26
Forward P/E
-35.96
PEG ratio
-35.96
Price/Sales (ttm)
2.02
Price/Book (mrq)
3.00
Enterprise Value/Revenue
1.28
Enterprise Value/EBITDA
-5.83
Overview
Shares outstanding
30.59M
Float
20.42M
Shares short
748.94K
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
307.87K
Average volume (90 days)
Price summary
52-Week low
16.56
52-Week high
30.60
52-Week change
-65.05%
Beta
1.51
50-Day moving average
19.48
200-Day moving average
21.08
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-59.39%
Operating margin
-23.81%
Operational effectiveness
Return on assets
-4.15%
Return on equity
-14.35%
Income statement
Revenue (ttm)
9.26
Revenue per share (ttm)
9.26
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
104.46M
EBITDA
71.08M
Net income to common (ttm)
-164,968,992.00
Diluted EPS (ttm)
-5.52
Quarterly earnings growth (yoy)
-15.28%
Balance sheet
Total cash (mrq)
213.07M
Total cash per share (mrq)
6.97
Total debt (mrq)
9.94M
Total Debt/Equity (mrq)
3.00
Current ratio (mrq)
441.30%
Book value per share (mrq)
37.28
Cash flow
Cash flow statement
10.98M
Levered free cash flow (LFCF)
-35,431,752.00